Earnings Preview: Hims & Hers Health
Portfolio Pulse from Benzinga Insights
Hims & Hers Health (NYSE:HIMS) is scheduled to release its quarterly earnings report on February 26, 2024, with an expected EPS of $-0.02. Analysts and investors will be looking for the company to beat this estimate and provide positive guidance for the next quarter. Historical data shows mixed reactions to past earnings reports, with share price movements varying significantly post-announcement. Currently, HIMS shares are trading at $9.45, down 1.55% over the last 52 weeks, indicating potential investor concern ahead of the earnings release.
February 23, 2024 | 2:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Hims & Hers Health is expected to report an EPS of $-0.02 for the upcoming quarter. Historical performance shows significant price changes post-earnings, with a recent 1.55% yearly decline in stock value.
Given HIMS's mixed historical earnings performance and the recent downward trend in stock price, the upcoming earnings report and particularly the guidance for the next quarter will be crucial for short-term stock movement. However, the score is neutral (0) due to the unpredictability of market reactions to earnings reports and guidance.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100